Nouveau Life Pharmaceuticals (Nouveau Life Pharmaceuticals) Debt-to-Equity : 1.51 (As of Mar. 2008)

Nouveau Life Pharmaceuticals Debt-to-Equity Chart

Nouveau Life Pharmaceuticals Quarterly Data
	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08
Debt-to-Equity	Get a 7-Day Free Trial															0.11	0.21	0.31	2.81	1.51

Competitive Comparison of Nouveau Life Pharmaceuticals's Debt-to-Equity

For the Health Information Services subindustry, Nouveau Life Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nouveau Life Pharmaceuticals's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nouveau Life Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Nouveau Life Pharmaceuticals's Debt-to-Equity falls into.

Nouveau Life Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Nouveau Life Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Jun. 2006 is calculated as

Nouveau Life Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Mar. 2008 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nouveau Life Pharmaceuticals  (OTCPK:NOUV) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Nouveau Life Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Nouveau Life Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nouveau Life Pharmaceuticals (Nouveau Life Pharmaceuticals) Business Description